Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative methods in pharmacovigilance: focus on signal detection.

Manfred Hauben1, Xiaofeng Zhou

  • 1Safety Evaluation and Epidemiology, Pfizer Inc., New York, New York 10021, USA. manfred.hauben@Pfizer.com

Drug Safety
|February 13, 2003
PubMed
Summary

Automated methods enhance pharmacovigilance by detecting unknown drug side effects. Understanding their statistical basis and limitations is crucial for drug safety professionals to effectively assess these tools.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same author

Verbal Expressions of Probability in Pharmacovigilance: Most Likely Too Ambiguous.

Clinical therapeutics·2026
Same author

A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.

Drug safety·2026
Same author

Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group.

Drug safety·2026
Same author

How LLMs can advance safety case intake-points to consider and insights from a proof of concept.

Therapeutic advances in drug safety·2025
Same author

Erector spinae plane block versus quadratus lumborum block for abdominal surgery: A systematic review and meta-analysis.

World journal of surgery·2024

Area of Science:

  • Pharmacovigilance and drug safety science.
  • Statistical methods in healthcare.
  • Regulatory science and pharmaceutical development.

Background:

  • Pharmacovigilance aims to identify previously unknown adverse drug events.
  • Traditional methods involve manual review of reported drug-event combinations.
  • Automated methods, like Bayesian data mining, offer advanced signal detection capabilities.

Purpose of the Study:

  • To demystify automated signal detection methods for drug safety professionals.
  • To provide a clear understanding of the evolution and application of these techniques.
  • To equip practitioners with the knowledge to critically evaluate and implement automated pharmacovigilance tools.

Main Methods:

  • Overview of the historical development of signal detection in pharmacovigilance.

Related Experiment Videos

  • Detailed explanation of key automated methods: proportional reporting ratios, Bayesian Confidence Propagation Neural Network, and empirical Bayes screening.
  • Exploration of underlying statistical concepts with supporting figures.

    • Main Results:

    • Automated methods can supplement or replace manual review for detecting adverse drug events.
    • Published evaluations are often limited to large regulatory databases, with potential performance differences in smaller developer databases.
    • Head-to-head comparisons of major techniques are lacking.

    Conclusions:

    • Drug safety professionals require a solid understanding of automated signal detection methods, including their strengths and limitations.
    • Mathematical complexity should not deter practitioners from effectively assessing and utilizing these techniques.
    • Informed application of automated methods enhances the overall safety assessment of medicines.